Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.

Address: Department of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.; Department of Medicine, University of California, San Diego, San Diego, CA, USA.; Renal-Electrolyte and Hypertension Division, Department of Medicine, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania, PA, USA.; AM-Pharma, Utrecht, The Netherlands.; Department of Anesthesiology, Lerner College of Medicine of Case Western University, Cleveland, OH, USA.; Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.; Bayer Pharmaceuticals, Cambridge, MA, USA.; Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Verpora Ltd, Nottingham, UK.; University of Portsmouth, UK.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.; Division of Chronic Care Management, Centers for Medicare & Medicaid Services, Woodlawn, MD, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, CA, USA.; Department of Biostatistics, University of Washington (UW), Seattle, WA, USA.; INI-CRCT Network, Nancy, France.; University of Lorraine, Inserm 1433 CIC-P CHRU de Nancy, Inserm U1116, Nancy, France.